Alex Therien of Merck joined us for Americas Antibody Congress 2016 to discuss ” prevention of recurrent CDIs with antitoxin antibody bezlotoxumab” .
In this presentation learn about Clostridium difficile infections (CDI), why they are a growing concern, and how they can be prevented.
Download this presentation to understand more about:
- The toxins of C. difficile: TcdA and TcdB
- CDI pathogenesis and progression
- Actoxumab and bezlotoxumab: human monoclonal antitoxin antibodies
and much more!
Get your copy here !
If you’re interested in learning more about CDIs and what can prevent them , join us at Americas Antibody Congress 2017 , held May 23-24 in San Diego, CA . This event is co-located with World Biosimilar Congress USA and Cell Culture World Congress USA.